Polyp Biopsy Market Report 2026

Polyp Biopsy Market Overview

• Polyp Biopsy market size has reached to $1.39 billion in 2025 • Expected to grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: The Increasing Prevalence Of Colorectal Cancer Is Driving The Polyp Biopsy Market Through Early Detection Needs • Market Trend: Cloud-Based AI Transforms Real-Time Detection in Colorectal Screening • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Polyp Biopsy Market?

A polyp biopsy is a medical procedure in which a healthcare professional removes a small tissue sample from an abnormal growth, known as a polyp, located on the lining of an organ or body cavity, for microscopic examination to determine the cellular characteristics, detect the presence of disease, and support accurate diagnosis and treatment planning. This procedure is commonly used to assess the nature of polyps, differentiate between benign and malignant conditions, and provide essential information for guiding further clinical management or surveillance strategies. The main types of polyp biopsy are colonoscopy, colposcopy-directed biopsy, esophagogastroduodenoscopy, and laryngoscopy. Colonoscopy with polyp biopsy is a medical procedure in which a flexible camera (colonoscope) is inserted into the colon to visualize the intestinal lining and remove tissue samples (polyps) for diagnostic analysis. The various techniques used in this are endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and conventional biopsy, which are distributed through channels including online sales channels, retail pharmacies, and others, and used in applications such as colorectal cancer, gastrointestinal disorders, and others, by end-users such as hospitals, diagnostic laboratories, and specialty clinics.

What Is The Polyp Biopsy Market Growth Forecast?

The polyp biopsy market size is expected to see strong growth in the next few years. It will grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to AI-assisted biopsy procedures, minimally invasive techniques, expansion of hospital and diagnostic laboratory adoption, integration with imaging and cloud platforms, development of novel biopsy tools. Major trends in the forecast period include colonoscopy biopsy, colposcopy-directed biopsy, esophagogastroduodenoscopy biopsy, laryngoscopy biopsy, endoscopic mucosal resection (emr).

Global Polyp Biopsy Market Segmentation

1) By Type: Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy 2) By Technique: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy 3) By Application: Colorectal Cancer, Gastrointestinal Disorders, Other Applications 4) By End-User: Hospitals, Specialty Clinics Subsegments: 1) By Colonoscopy: Diagnostic Colonoscopy, Therapeutic Colonoscopy 2) By Colposcopy-Directed Biopsy: Cervical Biopsy, Vaginal Biopsy, Vulvar Biopsy 3) By Esophagogastroduodenoscopy: Diagnostic Esophagogastroduodenoscopy, Therapeutic Esophagogastroduodenoscopy

What Is The Driver Of The Polyp Biopsy Market?

The increasing prevalence of colorectal cancer is expected to propel the growth of the polyp biopsy market going forward. Colorectal cancer is a malignant disease that originates in the colon or rectum, arising from abnormal and uncontrolled growth of epithelial cells lining the large intestine, and is characterized by its potential to invade surrounding tissues and metastasize to distant organs. The increasing prevalence of colorectal cancer is primarily driven by widespread dietary patterns high in processed foods and low in fiber, which promote chronic inflammation, alter gut microbiota, and facilitate the development of precancerous lesions that can progress to malignancy over time. Polyp biopsy helps in mitigating the impact of rising colorectal cancer prevalence by enabling early detection and histopathological evaluation of suspicious lesions, thereby supporting timely intervention and prevention of disease progression. For instance, in 2025, according to the American Cancer Society (ACS), a US-based non-profit organization, an estimated 107,320 new cases of colon cancer and 46,950 cases of rectal cancer are projected to be diagnosed in the United States in 2025, with approximately 52,900 deaths expected from these cancers. Therefore, the increasing prevalence of colorectal cancer is driving the growth of the polyp biopsy industry.

Key Players In The Global Polyp Biopsy Market

Major companies operating in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical

Global Polyp Biopsy Market Trends and Insights

Major companies operating in the polyp biopsy market are focusing on developing innovative advancements such as AI-assisted detection systems to enhance the detection of colorectal polyps and support early identification of potential cancerous lesions. An AI-assisted detection system is a technology that analyzes medical imaging in real-time to identify potential abnormalities and provide visual alerts to clinicians, supporting clinical decision-making without performing therapeutic interventions. For instance, in September 2024, Odin Medical Ltd., a US-based medical technology company affiliated with Olympus Corporation, launched CADDIE, a cloud-based AI endoscopic system. The CADDIE device leverages cloud-based artificial intelligence to analyze colonoscopy video in real time and highlight areas with suspected colorectal polyps, allowing endoscopists to make informed decisions during procedures. Clinical trials demonstrated that the system improves the adenoma detection rate without increasing procedural time or risk, underscoring its potential to enhance early detection and patient care.

What Are Latest Mergers And Acquisitions In The Polyp Biopsy Market?

In October 2024, Caldera Medical, a US-based company that manufactures medical devices, acquired UVision360, Inc., for an undisclosed amount. With this acquisition, Caldera Medical gains access to UVision360's advanced hysteroscopy technology, including the LUMINELLE Bx system, thereby enhancing its minimally invasive solutions for diagnosing and treating uterine conditions such as polyps, fibroids, and intrauterine pathology. UVision360 is a US-based hysteroscopy systems provider and the developer of the LUMINELLE hysteroscopy and cystoscopy systems.

Regional Outlook

North America was the largest region in the polyp biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Polyp Biopsy Market?

The polyp biopsy market consists of revenues earned by entities by providing services such as endoscopic ultrasound (EUS), capsule endoscopy, double-balloon enteroscopy, single-balloon enteroscopy, push enteroscopy, transnasal endoscopy, and transanal endoscopic microsurgery (TEM). The market value includes the value of related goods sold by the service provider or included within the service offering. The polyp biopsy market also includes sales of hot biopsy forceps, cold biopsy forceps, endoscopic snares, polypectomy snares, cytology brushes, biopsy needles (fine-needle aspiration needles, core biopsy needles), and endoscopic ultrasound needles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.